The Vanguard Group 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:08 pm Purchase |
2023-12-29 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
The Vanguard Group | 1,574,742 7.980% |
308,367 (+24.35%) |
Filing |
| 2023-02-09 11:25 am Purchase |
2022-12-30 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
The Vanguard Group | 1,266,375 7.400% |
143,314 (+12.76%) |
Filing |
| 2022-02-10 08:22 am Purchase |
2021-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
The Vanguard Group | 1,123,061 6.570% |
234,643 (+26.41%) |
Filing |
| 2021-02-10 11:22 am Purchase |
2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
The Vanguard Group | 888,418 5.740% |
102,977 (+13.11%) |
Filing |